Antitumor-related immune cells such as M1 macrophages, activated memory CD4 T cells, and resting dendritic cells demonstrated a strong positive correlation with RCD scores, whereas classical tumor-promoting immune cells like M2 macrophages were negatively associated with RCD levels (Fig. 4a). This evidence concerns the gene CD4 and neoplasm.